The US Court of Appeals for the Federal Circuit found that the US Patent and Trademark Office (PTO) erred in calculating a patent term adjustment (PTA) for a patent covering an oral osmotic form of an antihypertensive drug,...more
2/28/2019
/ Chevron Deference ,
European Patent Office ,
Failure to Prosecute ,
Information Disclosure Statement ,
Intellectual Property Litigation ,
Patent Applications ,
Patent Cooperation Treaty ,
Patent Litigation ,
Patent Oppositions ,
Patent Term Adjustment ,
Patent Terms ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Request for Continued Examination ,
Reversal ,
Statutory Interpretation ,
Summary Judgment ,
USPTO